We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
-6.27%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$16.8B
AUM Growth
+$3.24B
(+24%)
Cap. Flow
+$4.87B
Cap. Flow
% of AUM
28.99%
Top 10 Holdings %
Top 10 Hldgs %
10.37%
Holding
3,295
New
862
Increased
762
Reduced
768
Closed
837
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$169M |
| 2 |
Coca-Cola
KO
|
+$155M |
| 3 |
McDonald's
MCD
|
+$140M |
| 4 |
Mondelez International
MDLZ
|
+$127M |
| 5 |
DRE
Duke Realty Corp.
DRE
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$174M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$133M |
| 3 |
Workday
WDAY
|
+$110M |
| 4 |
Johnson & Johnson
JNJ
|
+$98.4M |
| 5 |
ConocoPhillips
COP
|
+$93.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.63% |
| 2 | Financials | 11.8% |
| 3 | Healthcare | 10.7% |
| 4 | Industrials | 9.22% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVBN
1751
DELISTED
Evans Bancorp Inc
EVBN
| $214K | ﹤0.01% |
+5,841
| New | +$214K |
|
1752
Codexis
CDXS
$161M
| $213K | ﹤0.01% |
35,068
-91,107
| -72% | -$733K |
|
1753
Northrim BanCorp
NRIM
$593M
| $212K | ﹤0.01% |
20,440
-1,880
| -8% | -$19.3K |
|
1754
Norwood Financial Corp
NWFL
$371M
| $212K | ﹤0.01% |
+7,962
| New | +$204K |
|
|
DMC
1755
Del Monte Corp
DMC
$1.4B
| $211K | ﹤0.01% |
+9,074
| New | +$253K |
|
1756
Lindsay Corp
LNN
$1.14B
| $211K | ﹤0.01% |
+1,472
| New | +$223K |
|
1757
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.1B
| $211K | ﹤0.01% |
4,211
-26,410
| -86% | -$1.49M |
|
1758
Varex Imaging
VREX
$467M
| $211K | ﹤0.01% |
9,989
-38,105
| -79% | -$833K |
|
1759
Celldex Therapeutics
CLDX
$2.91B
| $210K | ﹤0.01% |
+7,476
| New | +$229K |
|
|
CBAY
1760
DELISTED
Cymabay Therapeutics
CBAY
| $210K | ﹤0.01% |
60,024
+41,862
| +230% | +$150K |
|
1761
Braskem
BAK
$956M
| $209K | ﹤0.01% |
21,432
-13,342
| -38% | -$167K |
|
|
WCLD
1762
WisdomTree Cloud Computing Fund
WCLD
$273M
| $209K | ﹤0.01% |
7,855
-53,040
| -87% | -$1.59M |
|
1763
Gerdau
GGB
$9.6B
| $208K | ﹤0.01% |
57,951
-3,890,088
| -99% | -$14.1M |
|
1764
Upwork
UPWK
$1.18B
| $206K | ﹤0.01% |
+15,143
| New | +$285K |
|
|
AFT
1765
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
| $206K | ﹤0.01% |
16,457
| – | – |
|
|
CVAC
1766
DELISTED
CureVac
CVAC
| $205K | ﹤0.01% |
26,048
-48,163
| -65% | -$562K |
|
1767
Investar Holding Corp
ISTR
$414M
| $204K | ﹤0.01% |
+10,243
| New | +$223K |
|
1768
Matador Resources
MTDR
$5.96B
| $203K | ﹤0.01% |
4,152
-51,933
| -93% | -$2.8M |
|
1769
iShares Core S&P US Growth ETF
IUSG
$30.8B
| $202K | ﹤0.01% |
2,521
+1,847
| +274% | +$166K |
|
1770
LanzaTech
LNZA
$61.1M
| $202K | ﹤0.01% |
206
-99
| -32% | -$97.4K |
|
|
TTM
1771
DELISTED
Tata Motors Limited
TTM
| $202K | ﹤0.01% |
+8,316
| New | +$234K |
|
1772
Columbia Financial
CLBK
$1.14B
| $201K | ﹤0.01% |
+9,536
| New | +$206K |
|
1773
LSI Industries
LYTS
$844M
| $201K | ﹤0.01% |
26,124
+4,502
| +21% | +$31.4K |
|
1774
ProShares UltraPro Dow 30
UDOW
$819M
| $201K | ﹤0.01% |
10,406
+6,290
| +153% | +$168K |
|
1775
BlackRock Science and Technology Term Trust
BSTZ
$1.85B
| $199K | ﹤0.01% |
11,269
-4,300
| -28% | -$88.6K |
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2022 Portfolio in Review
As of Q3 2022, Qube Research & Technologies (QRT) held 3,295 positions worth $16.8B, up 24% from $13.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $4.87B of net new capital in Q3 2022, opening 862 new positions and adding to 762 existing holdings. Its largest new stake was Coca-Cola: 2,493,071 shares worth $140M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Marathon Petroleum, an estimated $174M trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2022 buy was Coca-Cola: 2,493,071 shares worth $140M.
- Qube Research & Technologies (QRT) added most to Visa in Q3 2022, an estimated $169M increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2022 reduction was Marathon Petroleum, cutting an estimated $174M.
- Qube Research & Technologies (QRT) fully exited Phillips 66 in Q3 2022, selling an estimated $86.2M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $16.8B portfolio in Q3 2022.
- Qube Research & Technologies (QRT) opened 862 new positions and closed 837 in Q3 2022.
- Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $16.8B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.